• Протек
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 2
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 4
    LEADERSHIP
    THROUGH PARTNERSHIP

The CV “PROTEK” is recognized as the most influential distributor of pharmaceutical market

The CV “PROTEK” is recognized as the most influential distributor of the Russian pharmaceutical market at year-end 2016. Leaders of the annual “Influence Rating of subjects of the pharmaceutical market of Russia” were announced on 16 February as part of a festive evening to celebrate the 23th  anniversary of the founding of the newspaper “Pharmaceutical Vestnik”.

“PROTEK” has been actively involved in the fulfillment of industry and government initiatives, implement the world's best practices and technologies, sets business ethic standards. Topping  the influence rating means  the recognition of our expertise in these areas,” – said the General Director of CV “PROTEK” Dmitry Pogrebinsky.

The next award was given to the Chairman of the Board of Directors of PAO “PROTEK” Vadim Yakunin as the most influential entrepreneur in 2016 and  the pharmacy network “Rigla” was awarded as the most influential pharmacy chainof Russia.

The Annual “Influence Rating of subjects of the pharmaceutical market of Russia” for 2016 is formed on the basis of 476 survey respondents from 26 Russian cities. An independent rating  was made by the “Romir” holding with the assistance of KPMG audit consulting company.

ZdravCity online service for reservation of medications launched a referral program

The clients can use this service in all pharmacies connected to the resource, i.e. about 15 thousand retail outlets ... more...

Protek Group’s Executives Ranked in the TOP 1000 Russian Managers Again

Vadim Muziaev, Protek Group’s President, Dmitry Pogrebinsky, CV PROTEK’s General Director and Aleksandr Filippov, Ri... more...

Protek Group of Companies included in the TOP 50 of RBC 500 rating

The holding has become 48-th in the list of the leading enterprises, which is one point higher, compared to the... more...